TY  - GEN
AU  - Perello, Joan
AU  - Gomez, M
AU  - Ferrer, MD
AU  - Rodriguez, NY
AU  - Salcedo, C
AU  - Buades-Fuster, Juan Manuel
AU  - Perez, MM
AU  - Torregrosa, JV
AU  - Martin, E
AU  - Maduell, F
PY  - 2018
DO  - 10.1007/s40620-018-0471-9
SN  - 1121-8428
UR  - https://hdl.handle.net/20.500.12105/22614
AB  - Background: Cardiovascular calcification (CVC) is a major concern in hemodialysis (HD) and the loss of endogenous modulators of calcification seems involved in the process. Phytate is an endogenous crystallization inhibitor and its low molecular mass...
LA  - eng
PB  - Springer
KW  - Cardiovascular calcification
KW  - End-stage renal disease
KW  - Hemodialysis
KW  - Phytate
KW  - Vascular Calcification
KW  - Hemodiafiltration
KW  - Phytic Acid
KW  - Creatinine
KW  - Calcium
KW  - Humans
KW  - Renal Dialysis
KW  - Dialysis Solutions
TI  - SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels
TY  - research article
ER  -